Axcella Health Inc. (AXLA)

Axcella Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Selling, General & Admin	12.35	15.82	18.71	16.8	15.78	8.41
Research & Development	29.23	56.98	43.14	37.04	41.66	25.49
Other Operating Expenses	0.01	-0.08	-0	0.01	0.03	0
Operating Expenses	41.58	72.8	61.85	53.84	57.44	33.9
Operating Income	-45.77	-76.99	-61.85	-53.84	-57.44	-33.9
Interest Income	0.69	0.5	0.14	0.31	1.81	0
Interest Expense	1.36	3.02	2.92	3.01	3.4	0
Other Expense / Income	1.8	1.68	0	-0.01	0.02	4.35
Pretax Income	-48.23	-81.19	-64.63	-56.53	-59.04	-36.07
Income Tax	1.8	1.18	2.49	2.28	0.94	-2.17
Net Income	-50.03	-82.36	-67.12	-58.81	-59.97	-36.07
Shares Outstanding (Basic)	74	54	38	32	17	17
Shares Outstanding (Diluted)	74	54	38	32	17	17
Shares Change	40.05%	42.63%	20.04%	90.96%	0.58%	-
EPS (Basic)	-0.90	-1.52	-1.76	-1.85	-3.61	-2.18
EPS (Diluted)	-0.90	-1.52	-1.76	-1.85	-3.61	-2.18
Free Cash Flow	-43.04	-70.01	-54.5	-50.01	-51.1	-31.37
Free Cash Flow Per Share	-0.58	-1.29	-1.43	-1.58	-3.07	-1.90
EBITDA	-35.44	-67.01	-61.85	-53.84	-57.39	-32.81
Depreciation & Amortization	0.27	0.41	0.29	0.42	0.66	1.07
EBIT	-35.71	-67.42	-62.13	-54.26	-58.05	-33.88

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.